ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

Kurzrock and Ferrara Join UCSD Moores Cancer Center

January 25, 2013

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

In Brief: Columbia Still In Running As Comprehensive Center In ’78; Illinois Withdraws Application

June 24, 1977

In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible”

January 13, 1984

Maryland’s Greenebaum Cancer Center Wins NCI Designation.

September 12, 2008